Prothrombin time (PT) is thought to be unreliable in cirrhotic patients to predict the risk of bleeding.
its clinical application. 5 In addition, we have calculated the area of parabolic segment of the 1st and 2nd derivatives of PT, which represent the entire dynamic cycle of the clot formation. What could be the impact of all these parameters as independent variables in predicting bleeding in patients with liver cirrhosis has been another crucial point of this study. Bleeding risk was investigated using both a hemorrhagic score and the clinical history positive for bleeding.
Moreover, because these patients have a precarious balance between bleeding and thrombosis, 6 we wished to know which of these two opposite phenomena was the most prevalent in this setting.
| ME THODS

| Study population
We studied 307 consecutive cirrhotic patients (224 males and 83 females, median age 63, range 36-88 years) referred to the outpatient unit (n = 147) or to the clinical ward (n = 160) of the Gastroenterology
Unit of the University Hospital of Cagliari from December 2014 to
July 2017. Diagnosis of cirrhosis was made based on clinical, laboratory, imaging, and histological criteria. Characteristics of the patients studied are presented in Table 1 . A control group of 115 healthy subjects (48 males and 67 females, median age 59, range 43-85 years)
were also studied. Informed consent was obtained from all patients and controls. Bleeding risk was assessed using a hemorrhagic score proposed by the American College of Chest Physician. 7 This score comes from a study, which has identified several independent risk factors for bleeding in 10.866 hospitalized medical patients; a score ≥7 indicated a high bleeding risk. 8 This hemorrhagic score was determined for each cirrhotic patient. Moreover, a clinical history positive for bleeding and/or for proven thrombotic episodes was obtained by recording documented events of each patient. In this way, we had information on a possible unbalance between thrombosis and bleeding. As the purpose of this study was to obtain data on a routine clinical and laboratory evaluation of the patients, our study did not require ethical considerations.
| Analytic techniques
Blood sampling was performed using Na Citrate 3.2% (0.109 M) vacuum bottles (Venosafe; Terumo Italia, Rome, Italy., 3.2%). Samples were centrifuged at 1500 g for 20 minutes at room temperature.
Plasma was separated, and the PT ratio (RecombiPlasTin 2G, HemosIL, Werfen, Barcelona, Spain), the functional fibrinogen assay (von Clauss method) (Q.F.A. Thrombin, HemosIL, Werfen, Barcelona, Spain), and the CWA were carried out within 15 minutes for each patient and control. The whole procedure required approximately 60 minutes from blood sampling to sample analysis. All tests were performed using an ACL TOP 500 CTS Family (Werfen, Barcelona, Spain) which uses a turbidimetric method for clot detection. In this type of automated coagulometer, 0% absorbance defines the pre-coagulation phase then the absorbance (mAbs) increases after the initiation of clotting. The parameters examined inside the clot waveform were as follows: (a) time at which maximum velocity of clot formation was reached (1st derivative, expressed as mAbs/s), (b) time at which maximum change in acceleration of clot formation was reached (2nd derivative, expressed as mAbs/s 2 ), and (c) the area of parabolic segment of the 1st and 2nd derivatives of PT which represents the entire dynamic cycle of the clot formation. This area was obtained applying the Archimedes theorem. In particular, we first calculated the triangle area using the formula: base x height/2, while the final area of parabolic segment was obtained calculating the 4/3 of the triangle area. 9 The platelet count was carried out by an automated cell counter (Beckman Coulter, Milan, Italy) using blood samples collected with EDTA K3.
| Statistical analysis
As the variables examined were not normally distributed, data are presented as median and ranges. Accordingly, the Mann-Whitney test for independent data, the non-parametric analysis of vari- TA B L E 3 All parameters studied in cirrhotic patients with high and low hemorrhagic score Table 2 shows that all the parameters included in the study were significantly different when compared between cirrhotic patients and healthy subjects.
High hemorrhagic score was present in 67 of 307 cirrhotic patients (22%), while low hemorrhagic score was detected in 240 of 307 of the patients (78%). Table 3 reports a significant difference for all the parameters studied between cirrhotic patients with low and high hemorrhagic score.
Moreover, in Table 4 Stepwise logistic regression analysis showed that PT ratio was the only variable significantly associated with the clinical history of bleeding while when we performed logistic regression using the hemorrhagic score as dependent variable, the stepwise model included PT ratio, and area of parabolic segment of the 1st derivative of PT. Interactions among the variables considered are presented in Table 5 . Moreover, to achieve a single score derived from the several measurements employed we assigned 2.5 points to the PT ratio and 4.0 points to the area of parabolic segment of the 1st derivative of PT, on the basis of the ORs obtained with the stepwise logistic regression. Therefore, the risk of bleeding ranged from 0 to 6.5 points.
This new score was challenged against the hemorrhagic score in a ROC analysis showing an AUC of 0.72, 95% CI: 0.67-0.77 (P < 0.0001). The negative predictive value for the risk of bleeding was 90%, 95% CI: 85%-93%. However, AUC value was lower, even if statistical significant, when a ROC analysis was carried out considering the clinical history of bleeding: 0.59, 95% CI: 0.53-0.65 (P = 0.0019). The negative predictive value for clinical history of bleeding was 65%, 95% CI: 59%-71%. In Table 6 
| D ISCUSS I ON
The aim of this study was to assess whether routine PT and the CWA could be associated with both indicators. Alongside the routine tests PT ratio, fibrinogen, and platelet count, we wanted to investigate whether the "hidden" parameters of PT could be associated with both a bleeding score and a clinical history positive for bleeding. In other words, we wished to know whether the presence of a coagulopathy could be associated with an easier tendency to bleed in this type of patients.
Recently, we published a report that showed how in a group of cirrhotic patients the derivatives of aPTT could be associated with a clinical history of bleeding or thrombosis. 10 In weakness of blood coagulation activity is present in these patients.
The study of CWA can be carried out even in patients with a high thrombotic risk in that it can assess a hypercoagulable state. 11 In this new study, we focused our attention on the PT ratio and its derivatives, the area of parabolic segment of the 1st and 2nd de- In the literature, it has been repeatedly stated that PT, expressed as both PT INR and PT ratio, has never shown a good predictive test for bleeding in cirrhotic patients undergoing liver biopsy or invasive procedures. 12, 13 However, it is worth noting that bleeding secondary to liver biopsy or invasive procedure may happen to anyone independently from suffering from liver disease. Despite the poor reputation of PT as a coagulation test in predicting bleeding in cirrhotic patients, 14 it seems, at least from our data, that bleeding may be associated with an alteration of PT. In particular, our data show that the PT ratio together with the area of parabolic segment of the 1st derivative of PT can be predictive of bleeding. It is known that PT is a generic test, even in cirrhotic patients, but it expresses the deficit of hepatic synthesis of coagulation factors, which is translated into a weaker blood clot in turn related to a bleeding tendency. In fact, the derivatives we have studied show that there is a weakness in the velocity and acceleration of the clot formation supporting the concept that PT can be useful to evaluate not only the synthetic coagulative asset of the patient but also its ability to form an appropriate clot.
Even the area of parabolic segment of the 1st derivative of PT, which expresses the whole process of fibrin formation, has shown to be a further indicator of this phenomenon. Although it is true that these patients are at a lower level between natural anticoagulants and procoagulants, it is also true that this balance is unstable as stated by TA B L E 6 Areas under the Curve (AUC) obtained for all parameters studied vs both the hemorrhagic score and the clinical history positive for bleeding patients on one hand while on the other it is able to explain, at least partially, why in liver cirrhosis bleeding may be so frequent.
In our patients, the clinical history positive for bleeding reveals that bleeding is often minor but considering both the hemorrhagic and the thrombotic events, we can say that the cirrhotic patient even if in an unstable state of balance between bleeding and thrombosis clearly suffers much more often from hemorrhagic events, at least considering our findings. In this study, we have also introduced the size of the area of parabolic segment of derivatives of PT that represents the entire dynamic process of clot formation. This parameter therefore globally expresses the defect of clot formation in these patients. The greater is the area of parabolic segment, the slower is the clot formation. Finally, as the AUC value of the new score was similar to those of the different variables included in this study we propose to implement it in the algorithm of the software of the coagulometer ACL TOP.
It could be possible that this new score if aggregated to PT ratio value could be useful to provide a single parameter immediately ready to assess the bleeding risk in the individual cirrhotic patient together with the hemorrhagic score. This study has several limits.
First, it is a retrospective study with a relatively small and heterogeneous sample of patients with liver cirrhosis. However, we were interested to achieve general information on the hemostatic function of these patients in order to develop a system to be predictive in a prospective study. Secondly, the inability to study the generation of thrombin in these subjects even if a study including this parameter has been planned. This study will consider perhaps two different pathophysiological ways of the activation of blood coagulation. In conclusion, this study has tried to revise the role of PT in patients with liver cirrhosis because CWA is addressed to the dynamic of clot formation while the latter is able to detect the final global amount of thrombin. 17 The interaction between these two measures may be of interest in the approach to both cirrhotic patients and other settings of pathological conditions. A comprehensive score to evaluate the bleeding risk is then proposed, but it needs to be validated by a prospective study.
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